IMMUCELL CORP /DE/ (NASDAQ:ICCC) filed a Form 8-K with the Securities and Exchange Commission on February 02, 2026, disclosing a material event.
IMMUCELL CORP /DE/'s stock currently trades at $6.11 with a market capitalization of $54.3M. The Healthcare company's stock moved following the disclosure.


